Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs

Weipin Niu1, Li Xu2, Jingwei Li3

  • 1Central Laboratory, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China.

Oncology Letters
|August 13, 2020
PubMed

Insights

The ethanol extract of Paris polyphylla (PPE) and its component polyphyllin II (PPII) show promise in fighting bladder cancer metastasis. PPII effectively inhibits cancer cell migration and invasion by regulating epithelial-mesenchymal transition (EMT) genes.

Area of Science:

  • Oncology
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • Epithelial-mesenchymal transition (EMT) is crucial for malignant tumor progression, including bladder cancer.
  • Traditional Chinese medicinal herbs possess demonstrated anticancer properties.
  • Investigating natural compounds for bladder cancer treatment is a key research area.

Purpose of the Study:

  • To screen bladder cancer sensitivity to six classic anti-inflammatory and detoxifying Chinese herbs.
  • To identify specific compounds within promising extracts that inhibit cancer cell metastasis.
  • To elucidate the molecular mechanisms by which these compounds affect EMT and invasion.

Main Methods:

  • In vitro treatment of bladder cancer cells with various herbal extracts and their monomer components.
  • Assessment of cell migration and invasion capabilities.
  • Analysis of key epithelial-mesenchymal transition (EMT)-associated gene and matrix metalloproteinase (MMP) expression levels.

Main Results:

  • Bladder cancer cells showed higher sensitivity to the ethanol extract of Paris polyphylla (PPE) compared to other tested herbs.
  • PPE significantly suppressed bladder cancer cell migration and invasion.
  • Polyphyllin II (PPII), a component of PPE, markedly inhibited cell migration and invasion, upregulated E-cadherin, and downregulated N-cadherin, snail, twist, MMP2, and MMP9.

Conclusions:

  • PPE and its component PPII exhibit antimetastatic effects against bladder cancer.
  • PPII suppresses bladder cancer cell metastasis by regulating EMT-associated genes and MMPs.
  • PPII represents a potential therapeutic candidate for inhibiting bladder cancer metastasis.